NCT02207075View on ClinicalTrials.gov

Measuring Active Microglia in Progressive Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Secondary Progressive Multiple Sclerosis
Interventions
DRUG

[C11]PK-1195 PET scan

PET scan with tracer \[C11\]PK-1195

Trial Locations (1)

10021

Weill Cornell Medical College, New York

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT02207075 - Measuring Active Microglia in Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter